1. Home
  2. Medical News
  3. Retina

Annexon to Report ARCHER Phase 2 Trial Results in Geographic Atrophy at ASRS

07/25/2023
Annexon to Report ARCHER Phase 2 Trial Results in Geographic Atrophy at ASRS image

Annexon announced the company will present results from the ongoing ARCHER phase 2 trial in patients with geographic atrophy (GA) at the American Society of Retina Specialists (ASRS) 2023 annual meeting taking place July 28-August 1, 2023 in Seattle.

Details of the presentation are as follows:

  • Date and Time: Sunday, July 30, 2023 at 9:00 am PT
  • Title: Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration with Intravitreal ANX007: Results of the ARCHER Study
  • Presenter: Jeffrey S. Heier, MD, Director of the Retina Service and Retina Research, Ophthalmic Consultants of Boston, and an investigator in ARCHER
  • Session: Dry AMD Symposium 2

Register

We're glad to see you're enjoying Modern Optometry…
but how about a more personalized experience?

Register for free